Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00175110 · ClinicalTrials.gov registry record · Phase 1
The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure
A Phase 1 study, sponsored by Tufts University.
- Completed
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
NCT00175110 is a Phase 1 study that has completed, run by Tufts University. The registered enrollment target is 66 participants.
The verdict
NCT00175110, a Phase 1 study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
The goal of this study is to find out whether the plant compounds present in Hibiscus sabdariffa, a plant commonly used in herbal tea blends and other beverages, will have a beneficial effect on blood pressure in people with mildly elevated blood pressure.
Interventions
- BEHAVIORAL herbal therapy/botanical therapy (Hibiscus sabdariffa)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00175110
The ClinicalTrials.gov registry entry for NCT00175110 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which herbal therapy/botanical therapy (Hibiscus sabdariffa) is the first listed.
NCT00175110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00175110 about?
NCT00175110 is a clinical study titled "The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure". The goal of this study is to find out whether the plant compounds present in Hibiscus sabdariffa, a plant commonly used in herbal tea blends and other beverages, will have a beneficial effect on blood pressure in people with mildly elevated blood pressure.
What is the current status of trial NCT00175110?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00175110?
The interventions under investigation include: herbal therapy/botanical therapy (Hibiscus sabdariffa) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00175110?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.